Corica, Bernadette https://orcid.org/0000-0001-9460-4435
Romiti, Giulio Francesco
Mei, Davide Antonio
Proietti, Marco
Zhang, Hui
Guo, Yutao
Lip, Gregory Y. H.
,
Funding for this research was provided by:
Innovative Research Group Project of the National Natural Science Foundation of China (82170309)
Article History
Received: 22 April 2024
Accepted: 10 September 2024
First Online: 28 October 2024
Declarations:
:
: The study was approved by the Central Medical Ethic Committee of Chinese PLA General Hospital and by local institutional review boards and was conducted in accordance with the Declaration of Helsinki and the Consolidated Standards of Reporting Trials (CONSORT) reporting guideline; all the patients gave their written informed consent.
: GFR reports consultancy for Boehringer Ingelheim and an educational grant from Anthos, outside the submitted work. No fees are directly received personally. MP is investigator of the AFFIRMO project on multimorbidity in AF, which has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 899871. GYHL has been consultant and speaker for BMS/Pfizer, Boehringer Ingelheim, Daiichi-Sankyo, Anthos. No fees are received personally. GYHL is a NIHR Senior Investigator and co-principal investigator of the AFFIRMO project on multimorbidity in AF, which has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 899871. All other authors have nothing to declare.